Video Latest - ecancer

FORTE: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma patients

Dr Elena Zamagni - University of Bologna, Bologna, Italy

10 Dec 2020

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

9 Dec 2020

EBCC-12 during COVID-19

Prof Etienne Brain - EORTC Breast cancer group chair

16 Oct 2020

Why don’t all European breast cancer patients get the most appropriate care?

Prof Philip Poortmans - Antwerp University, Antwerp, Belgium

15 Oct 2020

Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behaviour

Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon

8 Oct 2020

Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma

Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain

25 Sep 2020

Highlights from ESMO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada

25 Sep 2020

Overtreatment and surgery on the axilla

Dr Felix Jozsa - Chelsea & Westminster Hospital NHS Foundation Trust, London, UK

2 Sep 2020

Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research

Dr Akintunde Orunmuyi - University College Hospital, Ibadan, Nigeria

28 Aug 2020

Direction and reasoning behind the AORTIC African Cancer Dialogues

Host: Dr. Miriam Mutebi, Speaker: Dr. Nazik Hammad

6 Aug 2020

Meet the Expert: Daniel Seymour

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

1 Jul 2020

Reducing damage to swallowing muscles during radiotherapy for head and neck cancers

Prof Christopher Nutting - The Royal Marsden NHS Foundation Trust, London, UK

12 Jun 2020

Video